MoneyWorks4Me

Marksans Pharma informs about details of loss of share certificate

31 Aug 2021 Evaluate

Pursuant to Regulation 39(3) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Marksans Pharma has informed that the Company received request from shareholder, Pawan Kumar Ramesh Chand (Folio No. P003266) through Registrar and Transfer Agent, Bigshare Services on August 30, 2021 regarding issue of duplicate share certificate.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1853.50
Dr. Reddys Labs. 1202.80
Cipla 1397.20
Lupin 2090.00
Zydus Lifesciences 1202.00
View more..